Lightlake surges as FDA approves NARCAN Nasal Spray
NARCAN Nasal Spray is for the emergency treatment of known or suspected opioid overdose.
View ArticleAmpliPhi signs clinical trial agreement with University of Adelaide
The agreement is to conduct a Phase I trial of bacteriophage therapy for treating Staphylococcus aureus infections
View ArticleAcerus Pharma reports approval of ESTRACE Generic in Canada
Health Canada grants a Notice of Compliance for the generic version of ESTRACE
View ArticleLiberator Medical to be acquired for $181mln
C. R. Bard aims to enhance its presence in the home care market.
View ArticleFoot Locker results beat on strong demand for basketball, running shoes
The footwear retailer reports better same-store sales; shares rise in pre-market.
View ArticleNoble Energy postopones midstream unit IPO
The company says it will continue to evaluate the timing for the postponed offering "as market conditions develop."
View ArticleHorizon Pharma withdraws $1bn Depomed bid following court ruling
California court rules Horizon improperly used confidential information
View ArticleCumberland wins favorable ruling in Acetadote patent lawsuit
By ruling in Cumberland's favor, the court upheld the validity of the patent which encompasses Cumberland's EDTA-Free formulation and has a term until August 2025.
View ArticleKaloBios Pharma extends surge as Shkreli named CEO
Shkreli will work with the senior management to ensure continued operations.
View ArticleNimble Storage plummets on disappointing guidance
The network storage startup posted a wider-than-expected loss for the most recent quarter.
View ArticleAbercrombie shoots up on stronger Q3 revenue
Rebounding sales at the Hollister unit helped the retailer beat the Wall Street consensus.
View ArticleAGTC granted FDA orphan drug designation for gene therapy to treat achromatopsia
Achromatopsia is an inherited retinal disease caused by mutations in the CNGA3 gene.
View ArticleFirst Mining Finance to acquire Goldrush Resources
The deal implies a value of C$0.026 per Goldrush share
View ArticleCanAlaska says drilling to start at Patterson West
The Canadian exploration stage company said the current financing initiative announced October 28 has been postponed.
View ArticlePure Storage reports narrower-than-expected Q3 loss; shares gain
The solid-state array vendor's revenue more than doubled in the August-to-October quarter.
View ArticleImplant Sciences to explore strategic options; shares rise
The company says growing security needs for soft targets drives spending on security technologies.
View ArticleMedical Marijuana’s HempMeds reveals new anti-aging products
HempMeds and Kannaway will be showcasing the products to anti-aging doctors at A4M World Congress, due Dec. 10-13.
View ArticleAxxess Pharma signs manufacturing deal with SDC Nutrition
Under the agreement, SDC has reformulated and immediately begun manufacturing all of Axxess Pharma's Tapout protein powders.
View ArticleFederal Reserve hikes rates for the first time since 2006
The U.S. central bank raised its key federal funds rate to 0.25%, up from at or near zero percent.
View ArticleThursday's trending - pharma, Fed rates and Astrazeneca
The Fed and pharma world were among the trending stories of the day.....
View ArticleChimerix plummets on late stage trial failure
The company’s oral antiviral drug did not meet its phase 3 goal.
View ArticleWall Street ends lower as crude slumps
Oil fell more than 3 percent on U.S. oversupply worries, Saudi remarks
View ArticleCopper North closes $150,030 private placement
The Canadian mineral exploration company completes transactions and grants stock options.
View ArticleNiocorp gets US$1.0 million in first tranche financing
The additional investment will accelerate the Canadian company’s work toward completion of the Elk Creek feasibility study.
View ArticleTitan Pharma stock trading halted ahead of FDA meeting
The Advisory Committee of the U.S. FDA to discuss the new drug application for the company’s lead product candidate Probuphine
View ArticleElectronic Cigarettes boosted by $9mln financing
The principal use of the proceeds will be to fund a settlement agreement with Fontem Ventures.
View ArticleDel Taco expects Q4 revenue above Street view
The second-largest Mexican fast food chain provides 2016 outlook in line with market estimates.
View ArticleBrookfield Asset Management unit buys Colombia’s Isagen for $1.99 bn
The purchase price is payable in cash in U.S. dollars on the expected closing date of January 26.
View ArticleSFX Entertainment closed $20 mln financing
SFX said last week that it may file for bankruptcy to deal with its continuing debt troubles.
View ArticleGreenFlag to acquire Golden Mile Organics
Golden Mile holds an exclusive operator license for systems to be used in Canada for the purpose of processing commercial and private waste.
View Article
